Estimated cost-effectiveness and burden of disease associated with quadrivalent cell-based and egg-based influenza vaccines in Spain
Influenza is a viral respiratory disease that causes significant clinical and economic burden globally. Quadrivalent influenza vaccine (QIV) is frequently used to protect people who have a high-risk of developing influenza complications due to comorbidities. QIV offers protection against influenza A...
Saved in:
Main Authors: | Jesús Ruiz-Aragón (Author), Ray Gani (Author), Sergio Márquez (Author), Piedad Alvarez (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influenza burden averted with a cell-based quadrivalent seasonal influenza vaccine compared with egg-based quadrivalent seasonal influenza vaccine
by: Ian McGovern, et al.
Published: (2024) -
Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
by: Edward W. Thommes, et al.
Published: (2017) -
Quadrivalent cell culture influenza virus vaccine. Comparison to egg-derived vaccine
by: Alberto Pérez-Rubio, et al.
Published: (2020) -
Reply to letter from Alvarez et al.
by: Jesús Ruiz-Aragón, et al.
Published: (2021) -
Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population
by: Filippo Rumi, et al.
Published: (2023)